These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 30894518)

  • 1. Loss of the androgen receptor suppresses intrarenal calcium oxalate crystals deposition via altering macrophage recruitment/M2 polarization with change of the miR-185-5p/CSF-1 signals.
    Zhu W; Zhao Z; Chou F; Zuo L; Liu T; Yeh S; Bushinsky D; Zeng G; Chang C
    Cell Death Dis; 2019 Mar; 10(4):275. PubMed ID: 30894518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen receptor enhances kidney stone-CaOx crystal formation via modulation of oxalate biosynthesis & oxidative stress.
    Liang L; Li L; Tian J; Lee SO; Dang Q; Huang CK; Yeh S; Erturk E; Bushinsky D; Chang LS; He D; Chang C
    Mol Endocrinol; 2014 Aug; 28(8):1291-303. PubMed ID: 24956378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulforaphane elicts dual therapeutic effects on Renal Inflammatory Injury and crystal deposition in Calcium Oxalate Nephrocalcinosis.
    Liu H; Yang X; Tang K; Ye T; Duan C; Lv P; Yan L; Wu X; Chen Z; Liu J; Deng Y; Zeng G; Xing J; Ye Z; Xu H
    Theranostics; 2020; 10(16):7319-7334. PubMed ID: 32641994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AhR activation attenuates calcium oxalate nephrocalcinosis by diminishing M1 macrophage polarization and promoting M2 macrophage polarization.
    Yang X; Liu H; Ye T; Duan C; Lv P; Wu X; Liu J; Jiang K; Lu H; Yang H; Xia D; Peng E; Chen Z; Tang K; Ye Z
    Theranostics; 2020; 10(26):12011-12025. PubMed ID: 33204326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage Function in Calcium Oxalate Kidney Stone Formation: A Systematic Review of Literature.
    Taguchi K; Okada A; Unno R; Hamamoto S; Yasui T
    Front Immunol; 2021; 12():673690. PubMed ID: 34108970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Protective Roles of Estrogen Receptor
    Zhu W; Zhao Z; Chou FJ; Zuo L; Liu T; Bushinsky D; Chang C; Zeng G; Yeh S
    Oxid Med Cell Longev; 2019; 2019():5305014. PubMed ID: 31178964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sirtuin 3 suppresses the formation of renal calcium oxalate crystals through promoting M2 polarization of macrophages.
    Xi J; Chen Y; Jing J; Zhang Y; Liang C; Hao Z; Zhang L
    J Cell Physiol; 2019 Jul; 234(7):11463-11473. PubMed ID: 30588609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colony-stimulating factor-1 signaling suppresses renal crystal formation.
    Taguchi K; Okada A; Kitamura H; Yasui T; Naiki T; Hamamoto S; Ando R; Mizuno K; Kawai N; Tozawa K; Asano K; Tanaka M; Miyoshi I; Kohri K
    J Am Soc Nephrol; 2014 Aug; 25(8):1680-97. PubMed ID: 24578130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCR2 antagonist attenuates calcium oxalate-induced kidney oxidative stress and inflammation by regulating macrophage activation.
    Wang X; Xie L; Liu C
    Exp Anim; 2024 May; 73(2):211-222. PubMed ID: 38199255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short Chain Fatty Acids Prevent Glyoxylate-Induced Calcium Oxalate Stones by GPR43-Dependent Immunomodulatory Mechanism.
    Jin X; Jian Z; Chen X; Ma Y; Ma H; Liu Y; Gong L; Xiang L; Zhu S; Shu X; Qi S; Li H; Wang K
    Front Immunol; 2021; 12():729382. PubMed ID: 34675921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium Oxalate Differentiates Human Monocytes Into Inflammatory M1 Macrophages.
    Dominguez-Gutierrez PR; Kusmartsev S; Canales BK; Khan SR
    Front Immunol; 2018; 9():1863. PubMed ID: 30186283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of sirtuin 1 attenuates calcium oxalate-induced kidney injury by promoting macrophage polarization.
    Song BF; Li BJ; Ning JZ; Xia YQ; Ye ZH; Yuan TH; Yan XZ; Li L; Zhou XJ; Rao T; Li W; Cheng F
    Int Immunopharmacol; 2023 Aug; 121():110398. PubMed ID: 37301123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy for stone disease.
    Dominguez-Gutierrez PR; Kwenda EP; Khan SR; Canales BK
    Curr Opin Urol; 2020 Mar; 30(2):183-189. PubMed ID: 31913203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sirtuin1 inhibits calcium oxalate crystal-induced kidney injury by regulating TLR4 signaling and macrophage-mediated inflammatory activation.
    Duan C; Liu H; Yang X; Liu J; Deng Y; Wang T; Xing J; Hu Z; Xu H
    Cell Signal; 2023 Dec; 112():110887. PubMed ID: 37717713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation and characterization of a novel rat model of primary hyperoxaluria type 1 with a nonsense mutation in alanine-glyoxylate aminotransferase gene.
    Li Y; Zheng R; Xu G; Huang Y; Li Y; Li D; Geng H
    Am J Physiol Renal Physiol; 2021 Mar; 320(3):F475-F484. PubMed ID: 33491567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Resolvin D1 and Protectin D1 as Potential Therapeutic Agents for Treating Kidney Stones.
    Wang B; Wei J; Huangfu Q; Gao F; Qin L; Zhong J; Wen J; Ye Z; Yang X; Liu H
    Oxid Med Cell Longev; 2022; 2022():4345037. PubMed ID: 35251472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium oxalate crystals induce renal inflammation by NLRP3-mediated IL-1β secretion.
    Mulay SR; Kulkarni OP; Rupanagudi KV; Migliorini A; Darisipudi MN; Vilaysane A; Muruve D; Shi Y; Munro F; Liapis H; Anders HJ
    J Clin Invest; 2013 Jan; 123(1):236-46. PubMed ID: 23221343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deposition of calcium phosphate and calcium oxalate crystals in the kidneys.
    Khan SR; Glenton PA
    J Urol; 1995 Mar; 153(3 Pt 1):811-7. PubMed ID: 7861545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minipump induced hyperoxaluria and crystal deposition in rats: a model for calcium oxalate urolithiasis.
    Marengo SR; Chen D; MacLennan GT; Resnick MI; Jacobs GH
    J Urol; 2004 Mar; 171(3):1304-8. PubMed ID: 14767338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pioglitazone decreased renal calcium oxalate crystal formation by suppressing M1 macrophage polarization via the PPAR-γ-miR-23 axis.
    Chen Z; Yuan P; Sun X; Tang K; Liu H; Han S; Ye T; Liu X; Yang X; Zeng J; Yan L; Xing J; Xiao K; Ye Z; Xu H
    Am J Physiol Renal Physiol; 2019 Jul; 317(1):F137-F151. PubMed ID: 31091119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.